Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9259510rdf:typepubmed:Citationlld:pubmed
pubmed-article:9259510lifeskim:mentionsumls-concept:C0020944lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0332835lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0007012lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0032611lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0314672lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C0026051lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C2744539lld:lifeskim
pubmed-article:9259510lifeskim:mentionsumls-concept:C1321887lld:lifeskim
pubmed-article:9259510pubmed:issue17lld:pubmed
pubmed-article:9259510pubmed:dateCreated1997-12-2lld:pubmed
pubmed-article:9259510pubmed:abstractTextThe functionalization of polytetrafluoroethylene (PTFE) for human thrombomodulin (hTM) binding has been achieved by CO2 plasma activation and subsequent vapour phase graft polymerization of acrylic acid (AA). The PTFE surfaces after CO2 plasma treatment, AA grafting and hTM immobilization were characterized by attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS) and electron spin resonance (ESR) spectroscopy, as well as by zeta potential and wetting measurements to quantitatively control each step of modification. The activity of immobilized hTM was estimated by the protein C activation test.lld:pubmed
pubmed-article:9259510pubmed:languageenglld:pubmed
pubmed-article:9259510pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:citationSubsetIMlld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9259510pubmed:statusMEDLINElld:pubmed
pubmed-article:9259510pubmed:monthSeplld:pubmed
pubmed-article:9259510pubmed:issn0142-9612lld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:WernerCClld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:MüllerMMlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:SimonFFlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:IkadaYYlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:KönigUUlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:HermelGGlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:JacobaschH...lld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:GrundkeKKlld:pubmed
pubmed-article:9259510pubmed:authorpubmed-author:VasiletsV NVNlld:pubmed
pubmed-article:9259510pubmed:issnTypePrintlld:pubmed
pubmed-article:9259510pubmed:volume18lld:pubmed
pubmed-article:9259510pubmed:ownerNLMlld:pubmed
pubmed-article:9259510pubmed:authorsCompleteYlld:pubmed
pubmed-article:9259510pubmed:pagination1139-45lld:pubmed
pubmed-article:9259510pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:meshHeadingpubmed-meshheading:9259510-...lld:pubmed
pubmed-article:9259510pubmed:year1997lld:pubmed
pubmed-article:9259510pubmed:articleTitleMicrowave CO2 plasma-initiated vapour phase graft polymerization of acrylic acid onto polytetrafluoroethylene for immobilization of human thrombomodulin.lld:pubmed
pubmed-article:9259510pubmed:affiliationInstitute for Energy Problems of Chemical Physics, Chernogolovka, Russia.lld:pubmed
pubmed-article:9259510pubmed:publicationTypeJournal Articlelld:pubmed